Trial Profile
A Single-Center, Open-Label, Randomized, Two-Stage, Two-Way Crossover Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Oct 2020
Price :
$35
*
At a glance
- Drugs Cipepofol (Primary) ; Rifampicin
- Indications Anaesthesia
- Focus Pharmacokinetics
- Sponsors Sichuan Haisco Pharmaceutical
- 31 Jul 2019 Status changed from not yet recruiting to completed.
- 21 Feb 2019 Planned initiation date changed from 30 Jan 2019 to 30 Mar 2019.
- 09 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Apr 2019.